Literature DB >> 12969809

Immunophenotypic analysis of peripheral blood stem cell harvests from patients with multiple myeloma.

Gema Mateo1, Mercedes Corral, Julia Almeida, Consuelo López-Berges, maría Jesús Nieto, Antonia García-Marcos, Lourdes Vázquez, Consuelo del Cañizo, Alberto Orfao, Jesús F San Miguel.   

Abstract

BACKGROUND AND OBJECTIVES: Four-color multiparameter immunophenotyping has recently proven to be an attractive technique for evaluating the plasma cell (PC) compartment since it allows discrimination between myelomatous and normal PC. This study was designed to investigate: i) whether peripheral blood is less contaminated than bone marrow as a source for an autologous transplant; ii) the effect of growth factors on mobilizing myelomatous PC into peripheral blood; iii) the degree of contamination by myelomatous PC in apheresis samples; and iv) whether the number of PC increases during the last days of apheresis. DESIGN AND METHODS: Using 4-color antigen staining we investigated the composition of the PC compartment in 90 apheresis products from 40 patients with MM; in 17 cases bone marrow and peripheral blood samples were also simultaneously evaluated.
RESULTS: (i) All pre-mobilization bone marrow samples analyzed were always contaminated with myelomatous PC whereas only 41% of the post-mobilization peripheral blood samples were contaminated. Moreover, the use of peripheral blood would lead to a reduction of >5x10(5) infused myelomatous PC; (ii) mobilization with cytokines increased the number of circulating PC, generally because of an expansion of the normal PC population; (iii) forty-eight percent of all peripheral blood stem cell harvests were contaminated with myelomatous PC, although normal PC usually represented the predominant population; (iv) no significant changes were observed in the amount of contaminating myelomatous PC during the first three days of apheresis. INTERPRETATION AND
CONCLUSIONS: Multiparameter immunophenotyping is a useful approach for investigating the PC compartment in apheresis products.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12969809

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  3 in total

1.  Comparison of twin and autologous transplants for multiple myeloma.

Authors:  Asad Bashey; Waleska S Pérez; Mei-Jie Zhang; Kenneth C Anderson; Karen Ballen; James R Berenson; L Bik To; Rafael Fonseca; César O Freytes; Robert Peter Gale; John Gibson; Sergio A Giralt; Robert A Kyle; Hillard M Lazarus; Dipnarine Maharaj; Philip L McCarthy; Gustavo A Milone; Stephen Nimer; Santiago Pavlovsky; Donna E Reece; Gary Schiller; David H Vesole; Parameswaran Hari
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

2.  Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematological recovery.

Authors:  J S Ungerstedt; E Watz; K Uttervall; B-M Johansson; B E Wahlin; P Näsman; P Ljungman; A Gruber; U Axdorph Nygell; H Nahi
Journal:  Med Oncol       Date:  2011-07-22       Impact factor: 3.064

3.  Ten Color Multiparameter Flow Cytometry in Bone Marrow and Apheresis Products for Assessment and Outcome Prediction in Multiple Myeloma Patients.

Authors:  Veronika Riebl; Sandra Maria Dold; Dagmar Wider; Marie Follo; Gabriele Ihorst; Johannes M Waldschmidt; Johannes Jung; Michael Rassner; Christine Greil; Ralph Wäsch; Monika Engelhardt
Journal:  Front Oncol       Date:  2021-08-13       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.